EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, NVAX:

17 Sep 2025
LAST:

8.390

CHANGE:
 0.17		OPEN:
8.560		HIGH:
8.780		ASK:
0.910		VOLUME:
4.65M
CHG(%):
1.99		PREV:
8.560		LOW:
8.320		BID:
3.110		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
17 Sep 258.5608.7808.3208.3904.65M
16 Sep 258.1508.6708.0758.5606.16M
15 Sep 257.9808.1557.8758.0804.44M
12 Sep 258.2108.2907.8307.9807.18M
11 Sep 258.0258.3108.0108.2804.23M
10 Sep 258.0108.1907.8957.9602.99M
09 Sep 257.7408.0907.6657.9604.53M
08 Sep 257.8607.8607.6307.7303.5M
05 Sep 257.8907.9557.6617.9005.45M
04 Sep 257.4107.8207.2307.7907.38M

COMPANY PROFILE

Name:
About:Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Sector:Healthcare
Industry:Biotechnology
Address:700 Quince Orchard Road, Gaithersburg, MD, United States, 20878
Website:https://www.novavax.com
CUSIP:670002401
CIK:0001000694
ISIN:US6700024010
FIGI:BBG000NVSBL7
LEI:529900J4GJHPEPQ23205

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

P/E Ratio:4.29
Price to Book:41.92
Price to Sales:1.43
EBITDA:407.51M
Shares:162.42M
Market Cap:1.363B

TECHNICAL INDICATORS

MA5:8.26
MA10:8.06
MA20:7.87
MA50:7.73
MA100:7.25
MA200:7.61
STO9:62.86
STO14:71.74
RSI14:65.52
WPR14:-14.66
MTM14:0.81
ROC14:0.11
ATR:0.38
Week High:8.78
Week Low:7.83
Month High:10.64
Month Low:7.23
Year High:15.22
Year Low:5.01
Volatility:24.22

RECENT SPLITS

Date Ratio
10 May 20191-20